Glycobiology: Global Markets for Diagnostics and Therapeutics

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,500	123 Pages	BCC Research	March, 2023	WA17812482

Best Price Guarantee
Price	from $5,500
Length	123 Pages
Publisher	BCC Research
Published Date	March, 2023
SKU	WA17812482

Glycobiology: Global Markets for Diagnostics and Therapeutics

Report Scope:

The current report will provide an in-depth look at the glycobiology market. This report analyzes glycobiology market trends with data from 2021, estimates for 2022, projections of compound annual growth rates through 2027 (forecast period of 2022 to 2027), and regional market data. This report will highlight the current and future market potential of glycobiology along with providing a detailed analysis of the competitive environment. Regulatory scenarios, drivers, restraints, and opportunities will be covered in the current report. The report also covers market projections for 2027 and indicates the market share for key market players.

The scope of the market in this report is segmented into glycobiology segment and region. The segments of glycobiology are: glycobiology therapeutics, glycobiology diagnostics, and glycobiology reagents and tools. The regional markets are North America, Europe, Asia-Pacific, and other world regions (Rest of the World). Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India will be covered within their respective regional segments. For market estimates, data will be provided for 2021 as the base year, with forecasts for 2022 and 2027.

Report Includes:

51 tables

An up-to-date overview and analysis of the global markets for glycobiology diagnostics and therapeutics

Analyses of the global market trends, with historic revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027

Highlights of the market potential for glycobiology market, industry growth drivers, and areas of focus to forecast this market into various segments and subsegments

Estimation of the actual market size and revenue forecast for global glycobiology market in USD million terms, and corresponding market share analysis by major market segments and region

A look at new tools for synthesizing, modifying and studying oligosaccharides and glycoconjugates

Evaluation of promising candidates for carbohydrate-based diagnostics, drugs and vaccines

Insight into how glycobiology offers enormous untapped potential in the discovery of new therapeutics derived from saccharides or other molecules which target the biosynthesis and function of saccharides

Identification of leading biotechnology companies poised to introduce products during the forecast period, and their impact on the face of the competitive environment

Insight into recent industry structure for glycobiology diagnostics and therapeutics, current competitive scenario, clinical trials, ongoing research (R&D) activities, strategic alliances, and COVID-19 impact on the progress of this market

Profile descriptions of the major market players, including Agilent Technologies Inc., Bio-Techne, Merck KGaA, Takara Bio Inc. and Waters Corp.

Companies Mentioned

AGILENT TECHNOLOGIES
AMSBIO LLC
BIO-TECHNE
IsoSep
LUDGER LTD.
MERCK KGAA
NEW ENGLAND BIOLABS
TAKARA BIO INC.
THERMO FISHER SCIENTIFIC INC.
WATERS CORP.

Chapter 1 Introduction: 1.1 Overview; 1.2 Study Goals and Objectives; 1.3 Reasons for Doing This Study; 1.4 What's New in This Update?; 1.5 Scope of Report; 1.6 Information Sources; 1.7 Methodology; 1.8 Geographic Breakdown; 1.9 Analyst's Credentials; 1.10 BCC Custom Research; 1.11 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Dynamics: 3.1 Market Drivers; 3.1.1 Technological Advancements in the Analysis of Glycans; 3.1.2 Rising Prevalence of Chronic Disorders Globally; 3.1.3 Increasing R&D Investment by Pharma Companies; 3.2 Market Restraints; 3.2.1 Challenges in Glycobiology; 3.3 Market Opportunities; 3.3.1 Inorganic Strategies among Market Players
Chapter 4 Market Overview: 4.1 Overview; 4.1.1 Glycobiology; 4.1.2 Significance of Glycan; 4.1.3 Function of Glycans and Their Biological Significance; 4.1.4 Structural Role of Glycans; 4.1.5 Research Tools for Glycobiology Studies; 4.1.6 Structural Analysis of Glycans; 4.1.7 Glycomics as Part of Glycobiology Research; 4.1.8 Chemical and Enzymatic Synthesis of Glycans and Glycoconjugates; 4.1.9 Bioinformatics and Database Resources for Glycobiology Research; 4.2 Current Market Trends; 4.2.1 Protein and Glycan Glycoengineering; 4.2.2 Engineering Glycans and Glycan Mimics as Therapeutic Agents; 4.2.3 Glycobiology and Drug Delivery; 4.2.4 Oligosaccharide Libraries for Drug Discovery Research; 4.2.5 Glyconutrients as Therapeutics; 4.3 Recent Strategic Alliances; 4.4 Emerging Technologies; 4.4.1 Glycans in Medicine and Biotechnology; 4.4.2 Glycans in Nanotechnology, Bioenergy, and Materials Science
Chapter 5 Impact of COVID-19 on Market: 5.1 Overview; 5.2 COVID-19 Crisis; 5.2.1 Impact on Market for Glycobiology; 5.2.2 COVID-19 Measures
Chapter 6 Glycobiology Therapeutics Market: 6.1 Overview; 6.1.1 Subcategories of Glycobiology Therapeutics; 6.1.2 Therapeutic Glycoproteins; 6.1.3 Glycan Therapeutic Approaches to Metabolic Diseases; 6.1.4 Therapeutic Applications of Glycosaminoglycans; 6.1.5 Carbohydrate-based Vaccines and Glycans as Vaccine Components; 6.1.6 Blocking Glycan Recognition in Diseases; 6.1.7 Transfusion and Transplantation Rejection by Anti-glycan Antibodies
Chapter 7 Glycobiology Diagnostics Market: 7.1 Overview; 7.1.1 Glycobiomarkers and Autoimmunity; 7.1.2 Glycobiomarkers in Inflammatory Bowel Disease; 7.1.3 Autoantibodies Against Neuronal Glycans in Certain Neuropathies; 7.1.4 Glycobiology Markers in Cardiovascular Diseases; 7.1.5 Role of Glycans in the Histopathology of Alzheimer's Disease; 7.1.6 Glycobiomarkers and Asthma; 7.1.7 Glycobiomarkers in Infectious Disease Testing; 7.1.8 Market Potential for Glycobiology-based Biomarkers and Diagnostic Tests; 7.1.9 Glycobiology-based Cancer Biomarkers and Diagnostic Development; 7.1.10 Carbohydrates as Potential Serum Biomarkers; 7.1.11 Current Glycobiology-based Diagnostics on the Market; 7.1.12 Companies with Glycobiology Diagnostic Platforms and Products in Development; 7.1.13 Market for Glycobiology-based Diagnostics
Chapter 8 Glycobiology Reagents and Tools Market: 8.1 Overview; 8.1.1 Analytical and Chromatography Techniques; 8.1.2 Glycan Arrays; 8.1.3 Lectin Arrays; 8.1.4 Glycobiology Kits; 8.1.5 Reagents for Glycobiology Research; 8.1.6 Carbohydrates: Monosaccharides, Oligosaccharides and Other Reagents
Chapter 9 Market Breakdown by Region: 9.1 Overview; 9.1.1 North America; 9.1.2 Europe; 9.1.3 Asia-Pacific; 9.1.4 Rest of the World
Chapter 10 Analysis of Market Opportunities: 10.1 Porter's Five Forces Analysis; 10.1.1 Threat of New Entrants; 10.1.2 Threat of Substitutes; 10.1.3 Bargaining Power of Suppliers; 10.1.4 Bargaining Power of Buyers; 10.1.5 Degree of Competition
Chapter 11 Competitive Landscape
Chapter 12 Company Profiles: 12.1 Major Companies; AGILENT TECHNOLOGIES; AMSBIO LLC; BIO-TECHNE; ISOSEP; LUDGER LTD.; MERCK KGAA; NEW ENGLAND BIOLABS; TAKARA BIO INC.; THERMO FISHER SCIENTIFIC INC.; WATERS CORP.
Chapter 13 Appendix: Acronyms